Tyrin Lawrence
Story Poster
Keys to the Game: Texas A&M at Vanderbilt
10 mo ago by David Sandhop
Following an upset of then-No. 6 Tennessee, the Fightin' Texas Aggies travel to Nashville to face a struggling Vanderbilt squad inside Memorial Gymnasium. Winners in five of their last six games, the Maroon & White cannot afford an unexpected stumble in Music City.
Story Poster
Scouting Report: Texas A&M at Vanderbilt
10 mo ago by Tom Schuberth
Coming off a huge Saturday night win over a top-10 foe, Texas A&M travels to Nashville for a Tuesday evening clash with the Vanderbilt Commodores. Ahead of this Music City matchup, Jerry Stackhouse's 'Dores are sitting at 1-9 in conference play.
Story Poster
39:10
Surging Aggies wary of potential 'trap' game against Vanderbilt
10 mo ago by Olin Buchanan
Winners in five of their last six games, the Fightin' Texas Aggies have steadily climbed back up the Southeastern Conference standings. With a Tuesday night trip to Vanderbilt up next, Texas A&M cannot afford a detrimental blemish on its NCAA Tournament resume in Nashville.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
Advanced analysis of Texas A&M basketball's upcoming season
1 yr ago by David Sandhop
Fall sports are now in full swing, and excitement is already brewing for the 2023-24 campaign of A&M hoops tipping off in November. With plenty of experienced players returning and key talent added, Buzz Williams & Co. appear to rank among the best heading into this season.
Story Poster
25:03
A&M survives late Vanderbilt run to improve to 7-1 in conference, 72-66
1 yr ago by Olin Buchanan
After a nearly five-minute dry spell from the field, the Aggies pieced together a late 7-0 run to take control and defeat Vanderbilt, 72-66. For the first time in SEC play, A&M allowed more than 30 points in the first half but limited the 'Dores to just 34 percent shooting in the second.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.